<DOC>
	<DOC>NCT01050868</DOC>
	<brief_summary>This prospective, non-randomized, non-controlled, interventional study will determine whether the Roche automated bolus caclulator (ABC) reduces post-meal hyperglycemia better than the competitor's ABC without causing significant hypoglycemia.</brief_summary>
	<brief_title>Comparison of the Management of Post-prandial Hyperglycemia by Multiple Bolus Calculators</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 1</mesh_term>
	<criteria>Subjects &gt;/= 18 years at screening Type 1 diabetics currently using an insulin pump for management of their diabetes and have been on a pump for at least at least 6 months prior to the screening visit Subjects have to use a fast acting analog insulin HbA1c = 9% (measured with DCA 2000) Willing to perform periods of intensive blood glucose (BG) monitoring for up to 21 days prior to the study (~10 tests per day) with skipped meals and testmeals Willing to use the 3 different bolus calculators during the course of the study Willing to undergo planned hyperglycemia Willing to perform high frequency BG monitoring (&gt; 20 / day) during the experiment Type 2 Diabetes Manifest severe late complications of diabetes (e.g. severe macro or microangiopathy, severe neuropathy, severe retinopathy and/or severe nephropathy) Current addiction to alcohol or substances of abuse Pregnant or lactating women Any known lifethreatening disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
</DOC>